Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
MoonLake discloses up to $500M in financing; OSR’s deal with innovation fund
Last month
News Briefing
Exclusive: Daymark Health launches with $11.5M to care for cancer patients
Last month
Financing
Health Tech
Novartis’ Chinook-originated kidney disease drug gets accelerated approval
Last month
R&D
Sarepta, Roche pause Elevidys trials in Europe following patient death
Last month
R&D
Exclusive: Neurona bags $102M to treat epilepsy with cell therapy
Last month
Financing
Startups
Chaotic tariff rollout leaves as many questions as answers for drugmakers
Last month
Pharma
Manufacturing
Trump’s broad tariffs exempt pharma — but for how long?
Last month
Pharma
FDA+
FDA cuts stir buyer’s remorse for some biopharma leaders, once excited by Trump
Last month
Pharma
Cell/Gene Tx
FTC's fight against PBMs is paused
Last month
Pharma
Law
Day after mass FDA firings, new commissioner addresses remaining staff, focusing on 'MAHA' vision
Last month
FDA+
Eli Lilly adds obesity startup knownwell to its direct-to-consumer service
Last month
Startups
Pharma
Q&A: John Crowley warns biotech is 'dangerously close' to breaking, as tariff threat, markets batter industry
Last month
People
Pharma
Tang Capital's Concentra nabs a win, making a deal to buy Allakos
Last month
Deals
Roche says Ocrevus failed Phase 3 study; Sanofi licenses autoimmune asset from Nurix
Last month
News Briefing
Exclusive: Mikael Dolsten shares his post-Pfizer plans, including advising an AI unicorn with pharma dreams
Last month
People
AI
Atsena gets Bain's support in $150M Series C to thwart blindness with gene therapy
Last month
Financing
Startups
Edgewise's heart drug shows promise in Phase 2 trial
Last month
R&D
Arie Belldegrun nabs two leaders for Vida Ventures amid plans for fourth fund
Last month
People
New CDMO emerges, acquires cell and gene manufacturer Landmark Bio
Last month
Deals
Cell/Gene Tx
Judge orders HHS, other agencies to 'undo' probationary worker firings
Last month
Pharma
FDA+
‘It’ll be a challenge’: BIO chief Crowley addresses seismic FDA overhaul
Last month
People
Pharma
Eli Lilly sues large compounding pharmacies Empower, Strive over tirzepatide products
Last month
Pharma
Health Tech
RFK Jr. has long criticized drug ads. He just slashed the FDA office that regulates them
Last month
Pharma
FDA+
European drug regulator seeks to ‘streamline’ biosimilar approval process
Last month
Pharma
FDA+
First page
Previous page
19
20
21
22
23
24
25
Next page
Last page
Confirm Profile
Full Name
Email
Company
Job Title
{@!--CONSENT--!@}
Submit